259 related articles for article (PubMed ID: 22226634)
1. [Utilization of Essure® micro-insert for hydrosalpynx occlusion in infertile women].
Thébault N; Broux PL; Moy L; Vialard J
J Gynecol Obstet Biol Reprod (Paris); 2012 Apr; 41(2):145-50. PubMed ID: 22226634
[TBL] [Abstract][Full Text] [Related]
2. ICSI pregnancy outcomes following hysteroscopic placement of Essure devices for hydrosalpinx in laparoscopic contraindicated patients.
Ozgur K; Bulut H; Berkkanoglu M; Coetzee K; Kaya G
Reprod Biomed Online; 2014 Jul; 29(1):113-8. PubMed ID: 24813749
[TBL] [Abstract][Full Text] [Related]
3. [Adiana(®) hysteroscopic tubal occlusion device for the treatment of hydrosalpinx prior to in vitro fertilization: a case report].
Legendre G; Gallot V; Levaillant JM; Capmas P; Fernandez H
J Gynecol Obstet Biol Reprod (Paris); 2013 Jun; 42(4):401-4. PubMed ID: 23597488
[TBL] [Abstract][Full Text] [Related]
4. [Current position of Essure(®) micro-insert in the management of hydrolsalpinges before in vitro fertilization].
Sonigo C; Collinet P; Rubod C; Catteau-Jonard S
Gynecol Obstet Fertil; 2013 Feb; 41(2):133-8. PubMed ID: 23375476
[TBL] [Abstract][Full Text] [Related]
5. Hysteroscopic proximal tubal occlusion versus laparoscopic salpingectomy as a treatment for hydrosalpinges prior to IVF or ICSI: an RCT.
Dreyer K; Lier MC; Emanuel MH; Twisk JW; Mol BW; Schats R; Hompes PG; Mijatovic V
Hum Reprod; 2016 Sep; 31(9):2005-16. PubMed ID: 27209341
[TBL] [Abstract][Full Text] [Related]
6. Diagnostic accuracy of hysterosalpingo-foam-sonography to confirm tubal occlusion after Essure® placement as treatment for hydrosalpinges.
Dreyer K; Hompes PG; Mijatovic V
Reprod Biomed Online; 2015 Apr; 30(4):421-5. PubMed ID: 25682307
[TBL] [Abstract][Full Text] [Related]
7. Essure treatment of hydrosalpinges.
Hitkari JA; Singh SS; Shapiro HM; Leyland N
Fertil Steril; 2007 Dec; 88(6):1663-6. PubMed ID: 17490660
[TBL] [Abstract][Full Text] [Related]
8. In Vitro Fertilization Outcomes After Placement of Essure Microinserts in Patients With Hydrosalpinges Who Previously Failed In Vitro Fertilization Treatment: A Multicenter Study.
Cohen SB; Bouaziz J; Schiff E; Simon A; Nadjary M; Goldenberg M; Orvieto R; Revel A
J Minim Invasive Gynecol; 2016; 23(6):939-43. PubMed ID: 27257082
[TBL] [Abstract][Full Text] [Related]
9. Hysteroscopic tubal electrocoagulation versus laparoscopic tubal ligation for patients with hydrosalpinges undergoing in vitro fertilization.
El-Mazny A; Abou-Salem N; Hammam M; Saber W
Int J Gynaecol Obstet; 2015 Sep; 130(3):250-2. PubMed ID: 26140948
[TBL] [Abstract][Full Text] [Related]
10. Essure(®) for management of hydrosalpinx prior to in vitro fertilisation-a systematic review and pooled analysis.
Arora P; Arora RS; Cahill D
BJOG; 2014 Apr; 121(5):527-36. PubMed ID: 24393165
[TBL] [Abstract][Full Text] [Related]
11. Essure hysteroscopic tubal occlusion device for the treatment of hydrosalpinx prior to in vitro fertilization-embryo transfer in patients with a contraindication for laparoscopy.
Mijatovic V; Veersema S; Emanuel MH; Schats R; Hompes PG
Fertil Steril; 2010 Mar; 93(4):1338-42. PubMed ID: 19147140
[TBL] [Abstract][Full Text] [Related]
12. Essure a novel option for the treatment of hydrosalpinx: a case series and literature review.
Lorente González J; Ríos Castillo JE; Pomares Toro E; Romero Nieto MI; Castelo-Branco C; Arjona Berral JE
Gynecol Endocrinol; 2016; 32(2):166-70. PubMed ID: 26513546
[TBL] [Abstract][Full Text] [Related]
13. Safety and Assisted Reproductive Technology Outcomes of Hysteroscopic Tubal Microinserts Versus Laparoscopic Proximal Tubal Occlusion or Salpingectomy for Hydrosalpinges Treatment.
Arora R; Shapiro H; Liu K; Arthur R; Cruickshank B; Sharma P; Glass K; Baratz A; Librach C; Greenblatt EM
J Obstet Gynaecol Can; 2020 Jun; 42(6):779-786. PubMed ID: 32224160
[TBL] [Abstract][Full Text] [Related]
14. Hysteroscopic hydrosalpinx occlusion with Essure device in IVF patients when salpingectomy or laparoscopy is contraindicated.
Matorras R; Rabanal A; Prieto B; Diez S; Brouard I; Mendoza R; Exposito A
Eur J Obstet Gynecol Reprod Biol; 2013 Jul; 169(1):54-9. PubMed ID: 23561020
[TBL] [Abstract][Full Text] [Related]
15. Proximal occlusion of hydrosalpinges by Essure(®) before assisted reproduction techniques: a French survey.
Legendre G; Moulin J; Vialard J; Ziegler DD; Fanchin R; Pouly JL; Watrelot A; Belaisch Allart J; Massin N; Fernandez H
Eur J Obstet Gynecol Reprod Biol; 2014 Oct; 181():300-4. PubMed ID: 25201610
[TBL] [Abstract][Full Text] [Related]
16. [Successful pregnancies outcomes with the use of in vitro fertilization after Essure® unilateral hydrossalpinx occlusion].
Guedes-Martins L; Mesquita-Guimarães J; Barreiro M
Acta Med Port; 2014; 27(3):342-8. PubMed ID: 25017346
[TBL] [Abstract][Full Text] [Related]
17. Pregnancy after Essure placement: report of two cases.
Moses AW; Burgis JT; Bacon JL; Risinger J
Fertil Steril; 2008 Mar; 89(3):724.e9-11. PubMed ID: 17543963
[TBL] [Abstract][Full Text] [Related]
18. Essure multicenter off-label treatment for hydrosalpinx before in vitro fertilization.
Galen DI; Khan N; Richter KS
J Minim Invasive Gynecol; 2011; 18(3):338-42. PubMed ID: 21420911
[TBL] [Abstract][Full Text] [Related]
19. Is there a role for hysteroscopic tubal occlusion of functionless hydrosalpinges prior to IVF/ICSI in modern practice?
Darwish AM; El Saman AM
Acta Obstet Gynecol Scand; 2007; 86(12):1484-9. PubMed ID: 18027115
[TBL] [Abstract][Full Text] [Related]
20. Can laparoscopic removal of Essure device before embryo transfer correct poor reproductive outcome pattern in IVF? A case report.
Salem SA; Peck AC; Salem RD; Sills ES
Clin Exp Obstet Gynecol; 2014; 41(2):219-22. PubMed ID: 24779258
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
